Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease
Authors:
- Evelyne GineytsEGEvelyne Gineyts
- Marie-Claire ChapuyMCMarie-Claire Chapuy
- Pierre D. DelmasPDPierre D. Delmas
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Bone and Mineral
- Vol. 8 (1) , 87-96
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Evidence that free gamma carboxyglutamic acid circulates in serumClinica Chimica Acta, 1989
- Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease.Annals of the Rheumatic Diseases, 1986
- CROSS-LINKING IN COLLAGEN AND ELASTINAnnual Review of Biochemistry, 1984
- Aging and cross-linking in human aortaBiochemical and Biophysical Research Communications, 1982
- TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with paget's disease of bone and carcinoma with metastases in boneClinica Chimica Acta, 1979
- Pro—Gln: The procollagen peptidase cleavage site in the α1 (I) chain of dermatosparactic calf skin procollagenFEBS Letters, 1978
- Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.Journal of Clinical Investigation, 1977
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976
- Isotopic Studies on Collagen Degradation and the Urine Excretion of Hydroxyproline *Journal of Clinical Investigation, 1964